GlassScriptPhysician profile
Sharon T Cuffy
NPI 1619209129
$5,881.57
in general payments reported to CMS, 2019-2025
25 companies · $46.92 in 2025
The $46.92 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,389 · 2020: $99.69 · 2021: $510 · 2022: $2,388 · 2023: $737 · 2024: $711 · 2025: $46.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,685.77 | 2022-2023 | Senza |
| Smith+Nephew, INC. | $1,256.72 | 2019-2024 | Stravix Pl, Grafix Pl, Oasis |
| Stryker Corporation | $627.32 | 2022-2024 | Salvation, Citrefix, Prostep |
| Organogenesis INC. | $401.46 | 2019-2024 | Puraply |
| Paratek Pharmaceuticals, INC. | $250.98 | 2022-2024 | Nuzyra |
| Integra Lifesciences Corporation | $234.76 | 2019-2022 | |
| Lifenet Health | $150.66 | 2024 | Theragenesis Wound Matrix |
| Kci USA, INC. | $149.25 | 2019-2021 | |
| Osiris Therapeutics INC. | $141.04 | 2019 | |
| Wright Medical Technology, INC. | $135.83 | 2019 | |
| Biotissue Holdings INC. | $124.46 | 2023 | |
| Cook Medical LLC | $104.49 | 2019 | |
| Horizon Therapeutics Plc | $91.83 | 2019 | |
| Solventum Corporation | $84.99 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena Restor Axioform |
| Medtronic, INC. | $77.22 | 2023-2024 | Intellis Adaptivestim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $75.75 | 2022 | |
| Misonix INC | $51.83 | 2020-2021 | |
| Mimedx Group, INC. | $46.92 | 2025 | |
| Melinta Therapeutics, LLC | $40.81 | 2021 | |
| Reprise Biomedical, INC. | $37.50 | 2023 | Miro3d |
| Innovation Technologies INC | $30.25 | 2022 | |
| Aroa Biosurgery Incorporated | $28.22 | 2023 | |
| Treace Medical Concepts, INC. | $19.37 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $18.66 | 2023 | Seglentis |
| Bioventus LLC | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Cuffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.